China: MMJ research company opens Shanghai office
The opening of an office in China is the company's second major announcement involving the world's largest country and second largest consumer market in recent weeks. NSAV has previously announced an agreement in principle to acquire Chinese medical software company, Shanghai Hua Si Tai Medical Consultation Company Limited, which owns and operates Shanghai based Vital Strategic Research Institute (VSRI). VSRI is a medical research firm with a long history of expertise in design, clinical trials and global research.
James Tilton, president of NSAV stated, "I am tremendously excited that our flagship location in China will be in Shanghai, which is one of the world's leading business centers. Besides accounting for nearly 40% of the global production of cannabis sativa seeds, Chinese companies have 309 out of the 606 patents filed around the world that relate to cannabis. As one who has lived and worked in Shanghai, I can personally appreciate what an amazing city it is."
Mr. Tilton went on to state, "Again, I am fully aware from the dozens of shareholder emails and Tweets I received, that bringing NSAV current on its SEC filings is priority number one. I can assure all of you that it is my top priority as well. Unfortunately, I inherited an unexpectedly difficult situation from the previous management and it has caused a delay in bringing NSAV current. I am on top of this and I will fulfill my pledge to have the SEC filings completed very soon."
For more information:
www.facebook.com/Net-Savings-Link-Inc-768628693317257